This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hariharan, I K Articles by Adams, J M Search for Related Content PubMed PubMed Citation Articles by Hariharan, I K Articles by Adams, J M

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 July; 9(7): 2798-2805

A bcr-v-abl oncogene induces lymphomas in transgenic mice.

Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.

ABSTRACT

In chronic myeloid leukemia and some cases of acute lymphoblastic leukemia, a 9;22 chromosome translocation has fused most of the c-abl oncogene to a gene designated bcr. To explore in vivo the biological effects of the chimeric gene, we introduced a facsimile of the translocation product, a bcr-v-abl gene, into the mouse germ line under the control of the immunoglobulin heavy-chain enhancer or a retroviral long terminal repeat. Some transgenic mice bearing either construct developed clonal lymphoid tumors. T lymphomas predominated, but some pre-B lymphomas developed. The transgenes were expressed in the tumors but not detectably in the lymphoid tissues of nontumorous transgenic animals, implying that transcription is activated by a low-frequency somatic event. These results demonstrate that bcr-v-abl is tumorigenic in vivo and provide a new animal model for lymphomagenesis.

This article has been cited by other articles:

• Huettner, C. S., Koschmieder, S., Iwasaki, H., Iwasaki-Arai, J., Radomska, H. S., Akashi, K., Tenen, D. G. (2003). Inducible expression of BCR/ABL using human CD34 regulatory elements results in a megakaryocytic myeloproliferative syndrome. Blood 102: 3363-3370 [Abstract] [Full Text]  
• Sonoyama, J., Matsumura, I., Ezoe, S., Satoh, Y., Zhang, X., Kataoka, Y., Takai, E., Mizuki, M., Machii, T., Wakao, H., Kanakura, Y. (2002). Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells. J. Biol. Chem. 277: 8076-8082 [Abstract] [Full Text]  
• Nakajima, H., Zhao, R., Lund, T. C., Ward, J., Dolan, M., Hirsch, B., Miller, J. S. (2002). The BCR/ABL Transgene Causes Abnormal NK Cell Differentiation and Can Be Found in Circulating NK Cells of Advanced Phase Chronic Myelogenous Leukemia Patients. J. Immunol. 168: 643-650 [Abstract] [Full Text]  
• van der Kuip, H., Goetz, A. W., Miething, C., Duyster, J., Aulitzky, W. E. (2001). Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis. Blood 98: 1532-1541 [Abstract] [Full Text]  
• Deininger, M. W. N., Goldman, J. M., Melo, J. V. (2000). The molecular biology of chronic myeloid leukemia. Blood 96: 3343-3356 [Full Text]  
• Gross, A. W., Zhang, X., Ren, R. (1999). Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy. Mol. Cell. Biol. 19: 6918-6928 [Abstract] [Full Text]  
• Pear, W. S., Miller, J. P., Xu, L., Pui, J. C., Soffer, B., Quackenbush, R. C., Pendergast, A. M., Bronson, R., Aster, J. C., Scott, M. L., Baltimore, D. (1998). Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow. Blood 92: 3780-3792 [Abstract] [Full Text]  
• Zhang, X., Ren, R. (1998). Bcr-Abl Efficiently Induces a Myeloproliferative Disease and Production of Excess Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor in Mice: A Novel Model for Chronic Myelogenous Leukemia. Blood 92: 3829-3840 [Abstract] [Full Text]  
• Klucher, K. M., Lopez, D. V., Daley, G. Q. (1998). Secondary Mutation Maintains the Transformed State in BaF3 Cells With Inducible BCR/ABL Expression. Blood 91: 3927-3934 [Abstract] [Full Text]  
• Honda, H., Oda, H., Suzuki, T., Takahashi, T., Witte, O. N., Ozawa, K., Ishikawa, T., Yazaki, Y., Hirai, H. (1998). Development of Acute Lymphoblastic Leukemia and Myeloproliferative Disorder in Transgenic Mice Expressing p210bcr/abl: A Novel Transgenic Model for Human Ph1-Positive Leukemias. Blood 91: 2067-2075 [Abstract] [Full Text]  
• Castellanos, A., Pintado, B., Weruaga, E., Arevalo, R., Lopez, A., Orfao, A., Sanchez-Garcia, I. (1997). A BCR-ABLp190 Fusion Gene Made by Homologous Recombination Causes B-Cell Acute Lymphoblastic Leukemias in Chimeric Mice With Independence of the Endogenous bcr Product. Blood 90: 2168-2174 [Abstract] [Full Text]  
• Adams, J., Cory, S (1991). Transgenic models of tumor development. Science 254: 1161-1167 [Abstract]  
• Daley, G., Van Etten, R., Baltimore, D (1990). Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247: 824-830 [Abstract]